Dyadic International (DYAI) Gross Profit Growth (3y) (2021 - 2025)
Powered by 
Analysis
Dyadic International (DYAI) Gross Profit Growth (3y) (2021 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.70 Bn | 192.71 Bn | 7.24 Bn | 11.87% |
| 2 | Gilead Sciences | 180.18 Bn | 177.00 Bn | 6.22 Bn | 6.47% |
| 3 | Vertex Pharmaceuticals | 131.45 Bn | 123.60 Bn | 2.84 Bn | 9.20% |
| 4 | Regeneron Pharmaceuticals | 81.94 Bn | 73.95 Bn | 3.93 Bn | 10.09% |
| 5 | Argenx Se | 60.60 Bn | 55.42 Bn | 1.37 Bn | 77.42% |
| 6 | Moderna | 53.81 Bn | 48.67 Bn | 52.00 Mn | 28.75% |
| 7 | Alnylam Pharmaceuticals | 33.46 Bn | 30.15 Bn | 992.69 Mn | 59.77% |
| 8 | Biogen | 31.82 Bn | 30.54 Bn | 1.96 Bn | 1.69% |
| 9 | Roivant Sciences | 29.10 Bn | 29.10 Bn | 1.16 Mn | - |
| 10 | Dyadic International | 18.44 Mn | 10.48 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -26.71% |
| Dec 31, 2024 | 201.23% |
| Sep 30, 2024 | 73.23% |
| Jun 30, 2024 | -7.94% |
| Mar 31, 2024 | -86.02% |
| Dec 31, 2023 | 55.00% |
| Sep 30, 2023 | 24.90% |
| Jun 30, 2023 | 34.67% |
| Mar 31, 2023 | 89.01% |
| Dec 31, 2022 | -63.04% |
| Sep 30, 2022 | 58.35% |
| Jun 30, 2022 | 53.33% |
| Mar 31, 2022 | 48.36% |
| Dec 31, 2021 | -28.11% |
| Sep 30, 2021 | 148.59% |
| Jun 30, 2021 | 49.54% |
| Mar 31, 2021 | 1,129.63% |